CLOs on the Move

Q2 Solutions

www.q2labsolutions.com

 
Q² Solutions, a Quintiles Quest joint venture Launched in 2015, Q² Solutions (pronounced Q-squared) is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q² Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q² Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

StartUp Health

StartUp Health is organizing and supporting a global army of Health Transformers working on 10 Health Moonshots to improve the health and wellbeing of everyone in the world.

Acadian Companies

Acadian Companies is a Lafayette, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Airport Health Club

Airport Health Club is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Airport Health Club is based in Santa Rosa, CA. You can find more information on Airport Health Club at www.airportclub.com

Transcend Health

Transcend Health is a healthcare company that provides a digital health platform for first responders, encompassing health, physical fitness, training, and wellness. They also offer a Direct Primary Care model for employers to provide superior access t...

Relievant Medsystems

Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous Nerve Ablation System leverages proprietary instruments and methods to disable this nerve.